Subtype
Malignant Hepatobiliary Neoplasm
CI-CAN-00001136Explore in graph →
1,159 active trials17 approved drugs42 evidence items
- NCIt
- C8609
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001136Explore in graph →
Clinical trials
5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (563)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04844112 | CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation | completed | N/A | 139 | Seoul National University HospitalOTHER | 0 | Apr 14, 2021 | clinicaltrials |
| NCT00543777 | Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease | completed | Phase 1 / Phase 2 | 44 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03851471 | Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma | completed | Early Phase 1 | 10 | Zhong WangOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT01033240 | CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer | completed | Phase 2 | 172 | Daiichi SankyoINDUSTRY | 4 | Apr 8, 2021 | clinicaltrials |
| NCT01915589 | Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 16 | BayerINDUSTRY | 17 | Apr 8, 2021 | clinicaltrials |
| NCT01915602 | Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 14 | BayerINDUSTRY | 21 | Apr 8, 2021 | clinicaltrials |
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | completed | N/A | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT00877136 | A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® | completed | — | 18 | St. Joseph Hospital of OrangeOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT01755767 | Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy(METIV-HCC) | completed | Phase 3 | 383 | Daiichi SankyoINDUSTRY | 16 | Apr 6, 2021 | clinicaltrials |
| NCT02778308 | Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma | completed | N/A | 100 | Govind Ballabh Pant Institute of Postgraduate Medical Education and ResearchOTHER_GOV | 1 | Apr 6, 2021 | clinicaltrials |
| NCT02953743 | Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 25 | Eisai Co., Ltd.INDUSTRY | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04820712 | Surgical Therapy and Survival in HCC/ C.F. Zhang et al. | completed | — | 664 | Linzhu ZhaiOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT02670122 | Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC | completed | — | 131 | Instituto de Investigación Sanitaria de la Fundación Jiménez DíazOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT03888859 | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma | completed | Early Phase 1 | 12 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT04513457 | Chemotherapy for Resectable Colorectal Liver Metastases | completed | — | 967 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 3 | Mar 29, 2021 | clinicaltrials |
| NCT01967823 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04813861 | Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation(CELPerCutCHC) | completed | — | 57 | Central Hospital, Nancy, FranceOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03375281 | Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique | completed | N/A | 140 | Seoul National University HospitalOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT02832882 | RFA for Small HCC With No-touch Technique Using Octopus Electrode | completed | N/A | 118 | Seoul National University HospitalOTHER | 0 | Mar 22, 2021 | clinicaltrials |
| NCT03222258 | Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients | completed | — | 444 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT03389126 | Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment(AvelumabHCC) | completed | Phase 2 | 30 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04801719 | Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis | completed | N/A | 76 | Brno University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT02692911 | Chile Biliary Longitudinal Study | completed | — | 4,749 | National Cancer Institute (NCI)NIH | 1 | Mar 12, 2021 | clinicaltrials |
| NCT02642913 | Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients | completed | Phase 1 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04780789 | Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization | completed | — | 61 | Brno University HospitalOTHER | 0 | Mar 4, 2021 | clinicaltrials |
| NCT03405909 | Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study(ESCULAP) | completed | — | 517 | University Hospital ErlangenOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT02693847 | Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients | completed | — | 446 | Hospital Universitario de ValmeOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT03338062 | A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy | completed | N/A | 15 | Indiana UniversityOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04771988 | Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis | completed | — | 17 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT02273739 | Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation | completed | Phase 1 / Phase 2 | 21 | CelgeneINDUSTRY | 2 | Feb 23, 2021 | clinicaltrials |
| NCT02337465 | KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03254121 | Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response(HEPCASUS) | completed | — | 93 | Karolinska InstitutetOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03382327 | Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas(3D-HAPPI) | completed | N/A | 136 | IHU StrasbourgOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | completed | Phase 2 | 34 | Dong-A University HospitalOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04230642 | Multicenter Study to Evaluate a New Robotic Device for Image-guided Percutaneous Needle Placement | completed | N/A | 22 | Quantum SurgicalINDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT03830606 | The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma | completed | Phase 2 | 54 | Aiping ZhouUNKNOWN | 1 | Feb 1, 2021 | clinicaltrials |
| NCT04072679 | Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 1, 2021 | clinicaltrials |
| NCT01666756 | Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer | completed | Phase 1 | 18 | City of Hope Medical CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT01972672 | The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 70 | Beijing Shenogen Biomedical Co., LtdINDUSTRY | 1 | Jan 27, 2021 | clinicaltrials |
| NCT03307538 | Stereotactic Body Radiation Therapy for Unresectable Perihilar Cholangiocarcinoma(STRONG) | completed | N/A | 6 | Erasmus Medical CenterOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT03663114 | A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma | completed | — | 713 | Eisai Inc.INDUSTRY | 1 | Jan 22, 2021 | clinicaltrials |
| NCT04721470 | Combined Therapy for Hepatocellular Carcinoma >3-<5 cm | completed | N/A | 278 | Zagazig UniversityOTHER_GOV | 0 | Jan 22, 2021 | clinicaltrials |
| NCT02572687 | A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies | completed | Phase 1 | 85 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 20, 2021 | clinicaltrials |
| NCT04707547 | Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy(RFA) | completed | Phase 4 | 5 | Taipei Medical University WanFang HospitalOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT01246986 | A Study of LY2157299 in Participants With Hepatocellular Carcinoma | completed | Phase 2 | 204 | Eli Lilly and CompanyINDUSTRY | 7 | Jan 12, 2021 | clinicaltrials |
| NCT04510935 | Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro | completed | N/A | 35 | RenJi HospitalOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT02511821 | Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery | completed | N/A | 22 | City of Hope Medical CenterOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT03613168 | Trastuzumab in HER2-positive Biliary Tract Cancer(BILHER) | completed | Phase 2 | 4 | Changhoon YooOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT04692454 | Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | completed | N/A | 5 | Taipei Medical University WanFang HospitalOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04687280 | Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules(CHIC MultiA) | completed | — | 153 | University Hospital, AngersOTHER_GOV | 0 | Dec 29, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Apr 14, 2021source: clinicaltrials